Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD
Mediators of Inflammation · 2024-01 · 2024 (1)
DOI: 10.1155/2024/6263447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 09.07.2024. Verfasst von Min Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Key Laboratory of Respiratory Disease Research Traditional Chinese Medical Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830011, Xinj…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Butyrates, Mice, Inbred BALB C, Lymphocytes. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Group 2 innate lymphoid cells (ILC2) strongly modulate COPD pathogenesis. However, the significance of microbiota in ILC2s remains unelucidated. Herein, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) in regulating ILC2‐associated airway inflammation and explores its associated mechanism in COPD. In particular, we assessed the SCFA‐mediated regulation of survival, proliferation, and cytokine production in lung sorted ILC2s. To elucidate butyrate action in ILC2‐driven inflammatory response in COPD models, we administered butyrate to BALB/c mice via drinking water. We revealed that SCFAs, especially butyrate, derived from dietary fiber fermentation by gut microbiota inhibited pulmonary ILC2 functions and suppressed both IL‐13 and IL‐5 synthesis by murine ILC2s. Using in vivo and in vitro experimentation, we validated that butyrate significantly ameliorated ILC2‐induced inflammation. We further demonstrated that butyrate suppressed ILC2 proliferation and GATA3 expression. Additionally, butyrate potentially utilized histone deacetylase (HDAC) inhibition to enhance NFIL3 promoter acetylation, thereby augmenting its expression, which eventually inhibited cytokine production in ILC2s. Taken together, the aforementioned evidences demonstrated a previously unrecognized role of microbial‐derived SCFAs on pulmonary ILC2s in COPD. Moreover, our evidences suggest that metabolomics and gut microbiota modulation may prevent lung inflammation of COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Xinjiang Key Laboratory of Respiratory Disease Research Traditional Chinese Medical Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830011, Xinjiang, China.
- Department of Immunology College of Basic Medicine Xinjiang Medical University, Urumqi 830011, Xinjiang, China.
- Xinjiang Institute of Pediatrics Xinjiang Hospital of Beijing Children's Hospital Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830011, Xinjiang, China.
ORCID-Profile: Jing Wang, Fengsen Li, Jianbing Ding, Qifeng Li
Zitieren
APA
Jiang, M., Wang, J., Li, Z., Xu, D., Jing, J., Li, F., Ding, J., & Li, Q. (2024). Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD. Mediators of Inflammation, 2024(1). https://doi.org/10.1155/2024/6263447
Vancouver
Jiang M, Wang J, Li Z, Xu D, Jing J, Li F, et al. Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD. Mediators of Inflammation. 2024;2024(1). doi:10.1155/2024/6263447
BibTeX
@article{Jiang2024,
author = {Jiang, Min and Wang, Jing and Li, Zheng and Xu, Dan and Jing, Jing and Li, Fengsen and Ding, Jianbing and Li, Qifeng},
title = {Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD},
journal = {Mediators of Inflammation},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/6263447}
}
EUVIMED